Axiall Corporation (AXLL) - NYSE
  • Mon, Apr. 25, 3:48 PM
    • Westlake Chemical (WLK -1.8%) nominates nine candidates to replace Axiall's (AXLL -1.4%) board, saying the current board’s rejection of its improved takeover offer three weeks ago is not in the best interests of shareholders.
    • WLK says AXLL's "track record of value destruction and underperformance, repeated failed attempts to deliver on expectations, and in-process initiatives" are unlikely to generate value creation "anywhere near" that of its proposal.
    • WLK also says AXLL has not yet set a date for its annual meeting and tha the company may seek to delay the meeting and an opportunity for AXLL shareholders to voice their concerns in a formal manner.
    • Now read Axiall investors need to consider Westlake Chemical's interest
    | Mon, Apr. 25, 3:48 PM
  • Thu, Mar. 10, 3:19 PM
    • Axiall (AXLL +2%) is upgraded to Outperform from Market Perform with a $25 price target, up from $17, at Cowen, which expects Westlake Chemical (WLK +1.5%) will raise its takeover bid to at least $25 or that AXLL's actions will enhance a combination at a later date.
    • Cowen also thinks AXLL, excluding its building products business, could bring additional bidder interest due to its "pure play status.”
    • The firm believes AXLL’s FY 2017 EPS are set to increase by $0.54 in case of a $25/share offer and by $0.45 in case of a $30/share offer, assuming annual synergies of $60M.
    | Thu, Mar. 10, 3:19 PM
  • Fri, Jan. 29, 12:44 PM
    | Fri, Jan. 29, 12:44 PM
  • Fri, Jan. 29, 9:15 AM
    | Fri, Jan. 29, 9:15 AM
  • Fri, Jan. 29, 8:31 AM
    • Axiall (NYSE:AXLL) +73.4% premarket after Westlake Chemical (NYSE:WLK) announces it offered to acquire the company in a cash and stock deal valued at $2.9B, including the assumption of ~$1.5B of debt.
    • WLK says its proposal was "summarily rejected" by AXLL's board.
    • WLK says it offered $20.00/share, a 108% premium to AXLL's closing price of $9.60 on Jan. 22, the last trading day before WLK made its proposal; the deal comprised of $11/share in cash and 0.1967 of a WLK share, which represented a value of $9 based on WLK's Jan. 22 closing price.
    | Fri, Jan. 29, 8:31 AM | 8 Comments
  • Nov. 17, 2015, 4:49 PM
    • Axiall (NYSE:AXLL) appoints Timothy Mann as its new President and CEO after filling the roles in an interim capacity since July.
    • Mann had served earlier as executive VP responsible for strategy, as well as general counsel and secretary; prior to joining AXLL, he was a partner at the Jones Day law firm, where he focused mostly on M&An activities.
    • AXLL +1.7% AH.
    | Nov. 17, 2015, 4:49 PM
  • Sep. 2, 2015, 10:05 AM
    • UBS upgrades Olin (OLN -2.5%) to Neutral from Sell, believing OLN will be supported by its ~4% dividend yield and cost savings potential given the upcoming Reverse Morris Trust with Dow Chemical's chlorine-based business, but downgrades peer Axiall (AXLL -4.7%) to Sell from Neutral.
    • Although underlying fundamentals are challenged, UBS prefers OLN over AXLL on a relative basis since OLN has a 4% yield and AXLL pays no dividend, OLN should close its Reverse Morris Trust with Dow in early October, and AXLL is still the only major vinyls provider that is not back integrated to ethylene.
    | Sep. 2, 2015, 10:05 AM | 4 Comments
  • Jul. 6, 2015, 10:56 AM
    • Axiall (AXLL +3.1%) says Paul Carrico has retired as President, CEO and a board member, effective immediately, with no explanation given.
    • Timothy Mann Jr., executive VP of strategy, general counsel and secretary, will serve as interim President and CEO.
    • Franklin Resources, which owns a 6% active stake in AXLL, has said it believes the company should be more aggressive in taking actions to increase stockholder value.
    | Jul. 6, 2015, 10:56 AM
  • May 6, 2015, 11:18 AM
    • The big drop this morning in Axiall (AXLL -9.4%) is attributed to comments on the company's conference call discussing yesterday's IRS ruling on publicly traded partnerships.
    • AXLL says it is reviewing the IRS ruling but does not yet have an update on its private-letter ruling or the ultimate outcome of the rule-making process (Briefing.com).
    • Yesterday, the IRS proposed new rules that would bar chemical manufacturers from forming MLPs; Westlake Chemical Partners (WLKP -14.2%) also is slammed for a second straight day, but WLK +2.4%.
    | May 6, 2015, 11:18 AM | 3 Comments
  • Apr. 30, 2015, 5:40 PM
    | Apr. 30, 2015, 5:40 PM
  • Mar. 27, 2015, 3:27 PM
    • In a dig at Third Point's Daniel Loeb, Dow Chemical (DOW +3.2%) CEO Andrew Liveris says his company's decisive move to shift out of the commodity chemicals business shows how “Dow continues to behave as our own best activist.”
    • Dow's deal to sell its chlor-alkali business to Olin (OLN +18.2%) in exchange for $2B and a 50.5% stake in the smaller company will create the world’s largest chlorine producer with 5.7B tons/year of production and $1B in EBITDA.
    • Citigroup’s P.J. Juvekar offers three reasons why the deal is good for shareholders: The chlor-alkali divestiture at 8x EBITDA is a great multiple for a commodity business, the Reverse Morris Trust deal makes it tax-free and a split-off will allow Dow to buy back its own shares efficiently - a similar move by PPG Industries was viewed very positively two years ago, and Dow will sell ethylene to OLN for 20 years and will receive an upfront payment of ~$400M.
    • Dow may still get rid of its agricultural chemicals business, which does not have a lot in common with the rest of the business; with $7.3B in sales and almost $1B in EBITDA last year, the unit could be worth $10B.
    • Juvekar says Axiall (AXLL +5%) also could benefit from the deal, seeing consolidation in the U.S. chlor-alkali industry as a positive, and OLN says it will look to optimize its expanded chlor-alkali asset base.
    | Mar. 27, 2015, 3:27 PM
  • Mar. 23, 2015, 12:50 PM
    • Olin (OLN -3.8%) is downgraded to Sell from Neutral with a $25 price target at UBS, which says the sum of the parts argument for OLN following the Vista Outdoor spin is less compelling the higher the stock moves, and the firm believes channel inventory declines have not bottomed yet.
    • While OLN made positive comments about the potential for a chlorine/caustic recovery on its Q4 earnings call, the sentiment was not echoed by competitors Axiall (AXLL -1.2%) and Westlake (WLK +0.5%), and Dow Chemical (DOW +0.1%) is selling its operations partly because of depressed results.
    • UBS views chlor-alkali as a shale gas advantaged business, where supply has increased in recent years, plus the natural gas advantage has declined with the fall in oil prices.
    | Mar. 23, 2015, 12:50 PM | 4 Comments
  • Feb. 19, 2015, 10:46 AM
    • Axiall (AXLL +3.2%) says during its Q4 earnings conference call that it has been studying the possibility of creating a Chlor-Alkali MLP "as an opportunity to access low-cost capital and generate shareholder value," and has filed a ruling request with the IRS to determine if Chlor-Alkali qualifies.
    • AXLL saysit would finalize a feasibility study about the creation of an MLP if it receives a favorable ruling.
    • AXLL also says it will move its investment decision on a cracker to Q1 to allow time for additional analysis and clarity.
    • Earlier: Axiall beats by $0.03, misses on revenue
    | Feb. 19, 2015, 10:46 AM
  • Sep. 25, 2014, 2:08 PM
    • Dow Chemical (DOW -0.4%) has begun the process of selling its epoxy and chlorine businesses, and has hired Goldman Sachs and Barclays to manage the sale, Reuters reports.
    • The combined epoxy and chlorine businesses have annual EBITDA of close to $500M, and initial estimates place their combined value at $3.5B-$4B.
    • Logical buyers, according to the report, could include companies in the sector such as Axiall (AXLL -2.3%) and Westlake Chemical (WLK -2.2%), as well as P-E firms experienced in chemicals such as Apollo Global (APO -1.5%).
    | Sep. 25, 2014, 2:08 PM | 1 Comment
  • Jul. 10, 2014, 11:24 AM
    • After Axiall's (AXLL -3.1%) second straight negative earnings pre-announcement, Citigroup says investor patience is running thin and that an activist or an acquirer could take a look at the company.
    • Citi thinks LyondellBasell (LYB) “could afford” to take a look at AXLL, but notes that LYB has stated its preference for returning cash to shareholders over acquisitions; the firm cuts its AXLL price target to $48 from $49 and keeps a Neutral rating on the stock.
    • Cowen analysts say they would use any weakness in AXLL following the pre-announcement as a buying opportunity, seeing stronger PVC prices heading into Q3, due in part to competitor ethylene outages that could constrain PVC production.
    | Jul. 10, 2014, 11:24 AM
  • Jul. 9, 2014, 5:23 PM
    • Axiall (AXLL) -3.8% AH after reporting that its PHH vinyl chloride monomer manufacturing facility in Lake Charles, La., has returned to full operating rates, but the slow ramp up will result in lower than expected sales volumes and higher operating and maintenance costs during Q2.
    • Also, AXLL says it saw normal seasonal increases in U.S. building products sales volumes during Q2 along with weaker Canadian sales and the impact of a weaker Canadian dollar; operating income results in the aromatics segment will come in ~$12M lower than the year-ago Q2 due to lower operating rates and lower margins.
    | Jul. 9, 2014, 5:23 PM
Company Description
Axiall Corp. manufactures and markets chemicals and building products. It operates through two segments: Chlorovinyls and Building Products. The Chlorovinyls segment produces an integrated chain of products, including chlor-alkali and derivative products, such as chlorine, caustic soda, vinyl... More
Industry: Synthetics
Country: United States